Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroimmunol ; 27(2-3): 163-71, 1990 May.
Article in English | MEDLINE | ID: mdl-2139666

ABSTRACT

To characterize the effect of beta-endorphin on T-lymphocyte activation, we examined its influence on membrane currents, intracellular calcium flux, and c-myc mRNA levels during mitogenic stimulation of Jurkat cells. While beta-endorphin weakly enhanced voltage-activated K+ currents of Jurkat cells by itself, it suppressed these currents in the presence of mitogen. Naloxone, by itself, also enhanced K+ current amplitude, but in the presence of mitogen partially reversed the suppressive effect of beta-endorphin. A 5-30 min exposure to beta-endorphin resulted in an increase in the rate of mitogen-stimulated intracellular calcium release and an increase in c-myc mRNA levels relative to controls. Longer exposure (1-2 h) to beta-endorphin retarded intracellular calcium release, and suppressed c-myc expression. The suppressive effects were reversed by naloxone and mimicked by the K+ channel blocker, tetraethylammonium ion. These data suggest that opiate receptors and K+ channels of Jurkat cells are functionally coupled in a way that modulates intracellular calcium release and c-myc expression - two key processes in T-cell mitogenesis.


Subject(s)
Calcium/metabolism , Potassium Channels/drug effects , Proto-Oncogene Proteins/genetics , Proto-Oncogenes , T-Lymphocytes/drug effects , beta-Endorphin/pharmacology , Cell Line , Humans , Membrane Potentials , Naloxone/pharmacology , Proto-Oncogene Proteins c-myc , RNA, Messenger/analysis , T-Lymphocytes/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Tetraethylammonium Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...